302 related articles for article (PubMed ID: 22589302)
1. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
[TBL] [Abstract][Full Text] [Related]
2. Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
Syed Khaja AS; Dizeyi N; Kopparapu PK; Anagnostaki L; Härkönen P; Persson JL
PLoS One; 2013; 8(8):e72210. PubMed ID: 23991063
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1.
Lee TH; Seng S; Sekine M; Hinton C; Fu Y; Avraham HK; Avraham S
PLoS Med; 2007 Jun; 4(6):e186. PubMed ID: 17550303
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
[TBL] [Abstract][Full Text] [Related]
5. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.
Naumov GN; Bender E; Zurakowski D; Kang SY; Sampson D; Flynn E; Watnick RS; Straume O; Akslen LA; Folkman J; Almog N
J Natl Cancer Inst; 2006 Mar; 98(5):316-25. PubMed ID: 16507828
[TBL] [Abstract][Full Text] [Related]
6. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
[TBL] [Abstract][Full Text] [Related]
7. Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
Schuster C; Akslen LA; Straume O
PLoS One; 2016; 11(5):e0155242. PubMed ID: 27166673
[TBL] [Abstract][Full Text] [Related]
8. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
Musiani D; Konda JD; Pavan S; Torchiaro E; Sassi F; Noghero A; Erriquez J; Perera T; Olivero M; Di Renzo MF
FASEB J; 2014 Sep; 28(9):4055-67. PubMed ID: 24903273
[TBL] [Abstract][Full Text] [Related]
10. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
11. SU11248, a selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells.
Young E; Miele L; Tucker KB; Huang M; Wells J; Gu JW
Cancer Biol Ther; 2010 Oct; 10(7):703-11. PubMed ID: 20686367
[TBL] [Abstract][Full Text] [Related]
12. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
Kodama A; Sakai H; Matsuura S; Murakami M; Murai A; Mori T; Maruo K; Kimura T; Masegi T; Yanai T
BMC Cancer; 2009 Oct; 9():363. PubMed ID: 19825192
[TBL] [Abstract][Full Text] [Related]
13. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
[TBL] [Abstract][Full Text] [Related]
14. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
15. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK
Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107
[TBL] [Abstract][Full Text] [Related]
16. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
[TBL] [Abstract][Full Text] [Related]
17. Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.
Abdelkarim M; Vintonenko N; Starzec A; Robles A; Aubert J; Martin ML; Mourah S; Podgorniak MP; Rodrigues-Ferreira S; Nahmias C; Couraud PO; Doliger C; Sainte-Catherine O; Peyri N; Chen L; Mariau J; Etienne M; Perret GY; Crepin M; Poyet JL; Khatib AM; Di Benedetto M
PLoS One; 2011; 6(8):e23334. PubMed ID: 21858074
[TBL] [Abstract][Full Text] [Related]
18. Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction.
Lee YJ; Lee HJ; Choi SH; Jin YB; An HJ; Kang JH; Yoon SS; Lee YS
Angiogenesis; 2012 Jun; 15(2):229-42. PubMed ID: 22350794
[TBL] [Abstract][Full Text] [Related]
19. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
20. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]